Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
0(0%)
Results Posted
50%(4 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_1
1
5%
Ph phase_4
15
79%
Ph early_phase_1
1
5%
Ph phase_2
1
5%

Phase Distribution

2

Early Stage

1

Mid Stage

15

Late Stage

Phase Distribution18 total trials
Early Phase 1First-in-human
1(5.6%)
Phase 1Safety & dosage
1(5.6%)
Phase 2Efficacy & side effects
1(5.6%)
Phase 4Post-market surveillance
15(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

8 of 12 finished

Non-Completion Rate

33.3%

4 ended early

Currently Active

0

trials recruiting

Total Trials

19

all time

Status Distribution
Active(1)
Completed(8)
Terminated(4)
Other(6)

Detailed Status

Completed8
unknown6
Withdrawn3
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
0
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (5.6%)
Phase 11 (5.6%)
Phase 21 (5.6%)
Phase 415 (83.3%)

Trials by Status

enrolling_by_invitation15%
terminated15%
unknown632%
withdrawn316%
completed842%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT05620901Early Phase 1

DEXTENZA in Pediatric Patients Following Retinal Surgery or Laser Treatment Under Anesthesia

Completed
NCT06235567Phase 1

Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking

Enrolling By Invitation
NCT04977427Phase 4

Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes

Withdrawn
NCT05626478Phase 4

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

Completed
NCT05023304Phase 4

In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery

Completed
NCT04396990Phase 4

The RESTORE Study, A Randomized, Controlled, Masked (Reading Center) Prospective Study

Completed
NCT05372315Phase 4

Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL.

Completed
NCT04521140Phase 4

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery

Completed
NCT04839549Phase 4

Efficacy and Safety of Dextenza Compared to Topical Fluorometholone in Patients With Ocular Rosacea

Withdrawn
NCT04462523Phase 4

DEXTENZA for the Treatment of Postoperative Pain and Inflammation Following Vitreo-retinal Surgery

Completed
NCT05665270Phase 4

A Study for Post op Inflammation After Cataract Surgery

Unknown
NCT04563299Phase 4

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Terminated
NCT05587231Phase 4

Comparison of the Postoperative Use of Dextenza vs a Standard Regimen After PRK

Unknown
NCT04563559Phase 2

PREFERENTIAL Study

Withdrawn
NCT04975971

A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery

Completed
NCT04863742Phase 4

Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL

Unknown
NCT04530864Phase 4

Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy

Unknown
NCT04592081Phase 4

Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL.

Unknown
NCT04281862Phase 4

DEXTENZA Compared to Topical Prednisolone in Patients Undergoing Bilateral LASIK Surgery

Unknown

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19